Get unlimited access to our best features
Subscribe now

New combined therapy helps extend lives of men with prostate cancer

Summary by Ground News
A combination of androgen deprivation therapy and pelvic lymph node radiation kept nearly 90% of clinical trial patients at bay for five years. The findings were published in the peer-reviewed journal The Lancet. Prostate cancer is the most common non-skin cancer in the U.S., affecting 1 in every 6 to 7 men.
1 month ago

News Articles

More Filters
All
Left
Center
Right
Science Daily

New combined therapy helps extend lives of men with prostate cancer

Practice-changing research shows that a combination of androgen deprivation therapy -- a commonly used hormone injection -- plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.

1 month ago·United States
Read Full Article
Medical Xpress

New combined therapy helps extend lives of men with prostate cancer

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.

1 month ago
Read Full Article

New Combined Therapy Helps Extend Lives of Men With Prostate Cancer

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic l

1 month ago·Charlottesville, United States
Read Full Article

Similar News Topics

Show All
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

100% of the sources are Center
Science Daily
Medical Xpress
C 100%
Untracked bias
See less detail